Treatment logistics
Drug testing in treatment: Types, frequency, and what happens if you fail
Drug testing in treatment serves a clinical purpose, not a punitive one — though it can feel punitive when you are on the receiving end. Understanding how and why it works reduces anxiety and helps you engage with the process productively.
Types of tests
Urine drug screens (UDS) are the most common. They are inexpensive, easy to collect, and detect most substances within a 1-7 day window depending on the drug. Breathalyzers detect very recent alcohol use (within hours). Oral fluid (saliva) tests provide a shorter detection window than urine and are useful for detecting very recent use. Hair follicle tests detect use over a 90-day period but are expensive and less commonly used during treatment. Blood tests are rarely used in treatment settings except for specific medications (lithium levels, for example).
What is being tested for
Standard panels test for opioids, benzodiazepines, amphetamines, cocaine, THC, and alcohol. Expanded panels may add synthetic opioids (fentanyl), which standard opioid panels miss. If you are on MAT, your treatment provider will expect to see your prescribed medication (buprenorphine, methadone) in your results — its absence suggests you are not taking your medication, which is a clinical concern.
What happens if you test positive
In quality treatment programs, a positive test is treated as clinical information, not grounds for punishment or discharge. It triggers a conversation about what happened, an assessment of whether your treatment plan needs adjustment, possible medication changes, increased monitoring or therapy frequency, and in some cases, a step up to a higher level of care. Programs that immediately discharge patients for positive drug tests are acting against clinical best practices and ASAM guidelines. If your program threatens immediate discharge for any use during treatment, that is a red flag about the program's clinical approach.